Effects of glucose infusion on surfactant and glycogen regulation in fetal lamb lung.
To investigate the increased incidence of respiratory distress syndrome (RDS) that occurs in infants of diabetic mothers (IDM) with poor maternal glucose homeostasis, we infused glucose intravenously at a rate of 14 +/- 2 (SD) mg.kg-1.min-1 into eight twin and four singleton chronically catheterized fetal lambs from 112 days (0.77) gestation onward. Twelve catheterized and seven uncatheterized fetuses served as controls, including the eight twins of the glucose-treated fetuses. Glucose infusion resulted in a twofold elevation in fetal serum glucose levels and a 2.2-fold elevation in fetal serum insulin levels. Before 113 days (0.9) gestation, pulmonary disaturated phosphatidylcholine (DSPC) content was 1.5-fold higher in the glucose-infused fetuses than in the controls. However, after 0.9 gestation, pulmonary DSPC content increased 2.2-fold in the controls but did not increase significantly in the glucose-infused fetuses. In addition, the DSPC content of lung lavage was 5.0-fold higher in the controls and lung stability to air inflation was 2.0-fold greater and to deflation was 2.2-fold greater than in the glucose-infused fetuses. Pulmonary adenosine 3',5'-cyclic monophosphate-dependent protein kinase activity was also 1.5-fold higher, and pulmonary protein kinase C activity was 1.3-fold higher in the controls than in the glucose-infused fetuses. In contrast, glucose infusion was associated with a 1.8-fold increase in pulmonary glycogen content and with increased activities of glycogen phosphorylase kinase and glycogen phosphorylase. We conclude that the effects of chronic glucose infusion on fetal lamb lung DSPC and lung stability are compatible with a predisposition of the fetus to develop RDS.(ABSTRACT TRUNCATED AT 250 WORDS)
Warburton
D
D
Developmental Lung Biology Research Center, University of Southern California School of Medicine, Los Angeles.
Parton
L
L
Buckley
S
S
Cosico
L
L
Saluna
T
T
D000818:Animals; D001786:Blood Glucose / Q000493:pharmacokinetics*; D000242:Cyclic AMP / Q000502:physiology; D005260:Female; D005312:Fetal Blood / Q000378:metabolism; D006003:Glycogen / Q000096:biosynthesis*; D006801:Humans; D007231:Infant, Newborn; D008168:Lung / Q000196:embryology / Q000378:metabolism*; D008176:Lung Volume Measurements; D010713:Phosphatidylcholines / Q000378:metabolism*; D006005:Phosphorylases / Q000378:metabolism; D011247:Pregnancy; D011493:Protein Kinase C / Q000378:metabolism; D011494:Protein Kinases / Q000378:metabolism; D012127:Respiratory Distress Syndrome, Newborn / Q000503:physiopathology; D012756:Sheep
D001786:Blood Glucose; D010713:Phosphatidylcholines; D006003:Glycogen; D000242:Cyclic AMP; D006005:Phosphorylases; D011494:Protein Kinases; D011493:Protein Kinase C